![Royston Glasspool](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Royston Glasspool
Directeur/Membre du Conseil chez
RELMADA THERAPEUTICS, INC.
Fortune : - $ au 31/07/2026
Profil
Mr. Royston J.
Glasspool is a Chief Executive Officer at VarmX BV, an Independent Director at Relmada Therapeutics, Inc. and a Venture Partner at Agent Capital LLC.
He is on the Board of Directors at Relmada Therapeutics, Inc. and Biotechnology Innovation Organization.
Mr. Glasspool was previously employed as a Chief Executive Officer & Director by Anthos Therapeutics, Inc., an Independent Director by DalCor Pharmaceuticals Canada, Inc., an EVP, Head-Corporate Strategy & Customer Operations by Baxalta, Inc., a VP-Emerging Therapies & Market Development by Baxter BioScience Corp., a Director & Vice President by European Vaccine Manufacturers, and a Head-Marketing, Neuroscience by Novartis AG.
He received his undergraduate degree from Oxford Brookes University, an undergraduate degree from Staffordshire University and a graduate degree from Tufts University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Royston Glasspool
| Sociétés | Poste | Début |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 19/12/2019 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Private Equity Investor | 01/01/2018 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Directeur Général | 01/10/2024 |
Anciens postes connus de Royston Glasspool
| Sociétés | Poste | Fin |
|---|---|---|
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Directeur Général | 22/04/2024 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Directeur/Membre du Conseil | 01/01/2023 |
| BAXALTA INC | Corporate Officer/Principal | 01/01/2017 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 01/06/2015 |
European Vaccine Manufacturers | Directeur/Membre du Conseil | 01/12/2012 |
Formation de Royston Glasspool
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Oxford Brookes University
 Oxford Brookes University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Staffordshire University
 Staffordshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
European Vaccine Manufacturers | |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Develops precision treatments for cardiovascular disease | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
